Laboratorios Farmaceuticos Rovi SA

41L

Company Profile

  • Business description

    Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

  • Contact

    Julian Camarillo, 35
    Madrid28037
    ESP

    T: +34 913756230

    E: [email protected]

    https://www.rovi.es

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,188

Stocks News & Analysis

stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.
stocks

Most popular shares in SMSFs

With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,183.3036.30-0.39%
CAC 407,934.2616.260.21%
DAX 4024,387.93146.470.60%
Dow JONES (US)46,089.14609.541.34%
FTSE 1009,442.8715.400.16%
HKSE25,889.48400.84-1.52%
NASDAQ22,691.76487.332.19%
Nikkei 22548,088.80491.64-1.01%
NZX 50 Index13,351.92115.34-0.86%
S&P 5006,658.31105.801.61%
S&P/ASX 2008,882.8036.30-0.41%
SSE Composite Index3,889.507.53-0.19%

Market Movers